Age-related tumor mutational burden and inflammaging: a pan-cancer multi-omics study of treatment-naïve patients

This publication has 37 references indexed in Scilit:

• Hallmarks of aging: An expanding universe
  Cell, 2023
• Chemotherapy with or without avelumab followed by avelumab maintenance versus chemotherapy alone in patients with previously untreated epithelial ovarian cancer (JAVELIN Ovarian 100): an open-label, randomised, phase 3 trial
  The Lancet Oncology, 2021
• First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial
  The Lancet, 2021
• Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study
  The Lancet Oncology, 2020
• The Immune Landscape of Cancer
  Immunity, 2018
• The Molecular Signatures Database Hallmark Gene Set Collection
  Cell Systems, 2015
• Age and Cancer Risk
  American Journal of Preventive Medicine, 2014
• Immunity, Inflammation, and Cancer
  Cell, 2010
• Cluster-wise assessment of cluster stability
  Computational Statistics & Data Analysis, 2007
• A simulation study of the number of events per variable in logistic regression analysis
  Journal of Clinical Epidemiology, 1996